Association between angiographic complications and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention: an EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome) angiographic substudy.

[1]  S. Werns.  Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes , 2010 .

[2]  F. Burzotta,et al.  Myocardial no-reflow in humans. , 2009, Journal of the American College of Cardiology.

[3]  T. Akasaka,et al.  Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study. , 2009, European heart journal.

[4]  I. Porto,et al.  Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition. , 2009, QJM : monthly journal of the Association of Physicians.

[5]  Raimund Erbel,et al.  Impact of atherosclerotic plaque composition on coronary microembolization during percutaneous coronary interventions , 2008, Basic Research in Cardiology.

[6]  J. Ottervanger,et al.  Prognostic value of troponin after elective percutaneous coronary intervention: A meta‐analysis , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[7]  T. Kawamoto,et al.  The relationship between coronary plaque characteristics and small embolic particles during coronary stent implantation. , 2007, Journal of the American College of Cardiology.

[8]  R. Kornowski,et al.  Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality. , 2007, The American journal of cardiology.

[9]  Stefan Neubauer,et al.  Plaque Volume and Occurrence and Location of Periprocedural Myocardial Necrosis After Percutaneous Coronary Intervention: Insights From Delayed-Enhancement Magnetic Resonance Imaging, Thrombolysis in Myocardial Infarction Myocardial Perfusion Grade Analysis, and Intravascular Ultrasound , 2006, Circulation.

[10]  E. Topol,et al.  Angiographic adverse events, creatine kinase-MB elevation, and ischemic end points complicating percutaneous coronary intervention (a REPLACE-2 substudy). , 2006, The American journal of cardiology.

[11]  M. Borggrefe,et al.  Side branch occlusion after coronary stent implantation in patients presenting with ST-elevation myocardial infarction: clinical impact and angiographic predictors. , 2006, American heart journal.

[12]  R. Califf,et al.  The early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation acute coronary syndrome (EARLY ACS) trial: a randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non-ST-segment elevation acute coronary syndro , 2005, American heart journal.

[13]  E. Antman,et al.  Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction. , 2004, American heart journal.

[14]  G. Parodi,et al.  Impact of Microvascular Dysfunction on Left Ventricular Remodeling and Long-Term Clinical Outcome After Primary Coronary Angioplasty for Acute Myocardial Infarction , 2004, Circulation.

[15]  J. Ioannidis,et al.  Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention. , 2003, Journal of the American College of Cardiology.

[16]  M. Simoons,et al.  Minor Myocardial Damage and Prognosis: Are Spontaneous and Percutaneous Coronary Intervention–Related Events Different? , 2002, Circulation.

[17]  E. Antman,et al.  Combination Therapy With Abciximab Reduces Angiographically Evident Thrombus in Acute Myocardial Infarction: A TIMI 14 Substudy , 2001, Circulation.

[18]  C M Gibson,et al.  Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. , 2000, Circulation.

[19]  R. Califf,et al.  Minimal myocardial damage during coronary intervention is associated with impaired outcome. , 1999, European heart journal.

[20]  Katherine C. Wu,et al.  Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. , 1998, Circulation.

[21]  W. O’Neill,et al.  Incidence and angiographic predictors of side branch occlusion following high-pressure intracoronary stenting. , 1997, The American journal of cardiology.

[22]  E. Braunwald,et al.  TIMI frame count: a quantitative method of assessing coronary artery flow. , 1996, Circulation.

[23]  E. Topol,et al.  Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcomes. , 1993, Journal of the American College of Cardiology.

[24]  W. Ganz,et al.  The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.

[25]  H. S. Mueller,et al.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.